Based on the review of two separate FDA authorization requests submitted by Moderna, omicron boosters are anticipated to be available to children ages 6–11 in mid-October pending approval. Approval is also expected for babies between six months and five years old in the coming months, pending FDA approval.
The CDC has announced that its omicron booster vaccine will be available to children as soon as mid-October 2019. The vaccine, approved by the Food and Drug Administration (FDA) in August, could be made available as early as October 1. This means that children at risk for a certain variant of the Zika virus will have until October 2020 to enroll in the program. It is important for parents to know that state Medicaid programs often offer medications for vaccines similar to the one given to pregnant women.
The new shots are designed to be an express replacement for the previous PELL-COVID model vaccine (27-valent), and they're targeted at the Omicron BA.5 subvariant and an alternative strain of COVID that emerged in late 2019 in China. The FDA and CDC believe these new boosters offer more excellent protection because they target the most common strains of Omicron Ba.
0 Comments